The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores.
D000368:Aged; D001815:Bloodletting; D001853:Bone Marrow / Q000032:analysis; D003676:Deferoxamine / Q000494:pharmacology; D005243:Feces / Q000032:analysis; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000032:analysis / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000628:therapy*; D011166:Porphyrins / Q000032:analysis / Q000652:urine
D006454:Hemoglobins; D011166:Porphyrins; D007501:Iron; D003676:Deferoxamine